
The acquisition will advance innovation for patients with rare skin diseases

The company’s R&D and commercial expertise represent valuable capabilities for future Chinese partners

This is the first approved treatment option in the UK for patients with non-segmental vitiligo

UPPER NYACK, N.Y.--(BUSINESS WIRE)--The Global Healthy Living Foundation (GHLF) today announced a new partnership with Medscape Education to advance patient-centered innovation within the Immunology Learning Nexus (Nexus), Medscape’s flagship multi-year...

The alliance has already led to the delivery of functional antibody leads against a difficult-to-drug target

The inflammatory skin condition affects over 26 million people in the US

We are deeply saddened by the recent passing of Dr. Robert Sidbury. Dr. Sidbury was a visionary in pediatric dermatology whose dedication to advancing patient care inspired clinicians, researchers, and...

Spevigo is already approved in over 40 countries to treat generalised pustular psoriasis

Approximately 500,000 people worldwide are affected by the rare genetic skin disorders

The alliance will aim to discover molecules that could be incorporated into wider pharmaceutical research

Approximately 125 million people worldwide are affected by some form of the inflammatory condition

There is currently no cure for the group of rare inherited skin disorders